Abstract A variety of studies were considered necessary to better understand the etiology of idiopathic thrombocytopenic purpura. Apoptosis of platelets and megakaryocytes were strong proposals, calling for collaboration. Some groups want to study microparticles and thombin generation in order to understand the variation of the bleeding tendency in patients. Viral antigen cross-reaction with platelet epitopes was another topic that was addressed. Kinetics of cytokines may further contribute to our understanding of the disease.
Introduction
The group discussed the origins of idiopathic thrombocytopenic purpura (ITP) and the feeling that it has a variety of etiologies, even if acute onset and chronic (in adulthood) are already considered separately. Further, this variety may persist after excluding "secondary" ITP in diseases like lupus erythematosus. The following suggestions for further directions of research may assist to characterize better the pathoetiology of the disease.
As acute ITP is thought to be associated with viral infections, characterization of cross-reacting viral and platelets epitopes was suggested [1, 2] . This could be accomplished by work on the 3-D structures of the epitopes on the one hand, and by the production of the relevant peptides and antibody binding studies on the other hand. However, none of the participants has the necessary expertise to carry on such investigations.
It is clear that the platelet count is only a surrogate marker for the risk of bleeding. However, some individuals hardly have bleedings at very low platelet counts of <20× 10 9 /l while others may bleed at a platelet count of <50× 10 9 /l. Therefore, a very good characterization of platelets, megakaryocytes, and plasma factors for coagulation active mechanisms was felt necessary.
(a) In particular, platelet and megakaryocyte apoptosis was suggested to be of importance [3, 4] . The group around Oliver Speer and Markus Schmugge (University Children's Hospital, Zürich, Switzerland) is interested in such studies and called for collaboration with other groups to provide carefully defined sera or plasma from patients as well as providing bone marrow material. Material obtained at various periods throughout the disease would be advantageous for such studies. A study proposal is shown at the end of this report. (b) A possible compensation of the coagulation system for the low platelet count that is met in some individuals, but not in others, may contribute to less bleeding. Therefore, microparticles and thrombin generation may serve to overcome the low platelet counts [5] . Some groups have started to look into these mechanisms.
Another topic is cytokine regulation on serially obtained samples. John Semple (Toronto, Canada) would be interested in such studies. Such studies may advance our knowledge on T cell/B cell interaction during the course of the disease. Currently, the main body of data has been published on single observation snapshots [6] [7] [8] .
Familiar onset of ITP and genetic predisposition is a very interesting subject [9, 10] . Johannes Rischewski, Basel, is collecting these samples and studies family genetics. Again, collaboration with others would improve the power of these investigations.
